Atricure to participate at upcoming investor conferences

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in two upcoming investor conferences. atricure will be participating in the canaccord genuity 43rd annual growth conference. atricure's management is scheduled to present on thursday, august 10, 2023, at 8:00 a.m. east.
ATRC Ratings Summary
ATRC Quant Ranking